BioNexus Gene Lab Corp. (BGLC) Research

BioNexus Gene Lab Corp. (BGLC), established in 2017 and headquartered in Kuala Lumpur, Malaysia, conducts business through two primary subsidiaries. Its subsidiary, Chemrex Corporation Sdn. Bhd., specializes in the wholesale distribution of chemical raw material products across Malaysia, Indonesia, Vietnam, and other nations within Southeast Asia. These essential chemicals are utilized in the manufacturing of a wide array of products, including handrails, bench tops, components for the automotive and aerospace industries, cleanroom panels, and various instruments. Additionally, through its other subsidiary, BioNexus Gene Lab Sdn. Bhd., the company is involved in the development and provision of non-invasive liquid biopsy tests, designed for the early detection of biomarkers.

Market snapshot

Symbol
BGLC
Price
$2.61
Day change
+3.57%
Market cap
$5.3M
P/E ratio
-2.17x
52-week range
1.07-15.6
Sector
Healthcare
Industry
Medical - Diagnostics & Research

Peer companies

  • Advanced Biomed Inc. Common Stock (ADVB)
  • AEON Biopharma, Inc. (AEON)
  • Aptorum Group Limited (APM)
  • Check-Cap Ltd. (CHEK)
  • Galecto, Inc. (GLTO)
  • Lifeward Ltd. (LFWD)
  • Lyra Therapeutics, Inc. (LYRA)
  • Mustang Bio, Inc. (MBIO)

Recent insider activity

  • Wong Yee Meng — trade (0 shares) on 2023-07-19
  • Yap Chee Keong — trade (0 shares) on 2023-07-19
  • Yew Chak Hua — trade (0 shares) on 2023-07-19
  • Lin Chai Ping — trade (0 shares) on 2023-07-19
  • Teoh Boon Teong — trade (0 shares) on 2023-07-19

Open BioNexus Gene Lab Corp. (BGLC) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.